191 related articles for article (PubMed ID: 9075139)
1. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance.
Posthuma N; ter Wee PM; Verbrugh HA; Oe PL; Peers E; Sayers J; Donker AJ
Nephrol Dial Transplant; 1997 Mar; 12(3):550-3. PubMed ID: 9075139
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
3. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis.
Woodrow G; Stables G; Oldroyd B; Gibson J; Turney JH; Brownjohn AM
Nephrol Dial Transplant; 1999 Jun; 14(6):1530-5. PubMed ID: 10383020
[TBL] [Abstract][Full Text] [Related]
4. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.
Akonur A; Guest S; Sloand JA; Leypoldt JK
Perit Dial Int; 2013; 33(6):646-54. PubMed ID: 24335125
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
[TBL] [Abstract][Full Text] [Related]
6. Long daytime exchange in children on continuous cycling peritoneal dialysis: preservation of drained volume because of icodextrin use.
Michallat AC; Dheu C; Loichot C; Danner S; Fischbach M
Adv Perit Dial; 2005; 21():195-9. PubMed ID: 16686317
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
8. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; van Dorp W; Peers EM; Verbrugh HA
Perit Dial Int; 1997; 17(6):602-7. PubMed ID: 9655161
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism.
de Boer AW; Schröder CH; van Vliet R; Willems JL; Monnens LA
Pediatr Nephrol; 2000 Nov; 15(1-2):21-4. PubMed ID: 11095005
[TBL] [Abstract][Full Text] [Related]
10. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.
Finkelstein F; Healy H; Abu-Alfa A; Ahmad S; Brown F; Gehr T; Nash K; Sorkin M; Mujais S
J Am Soc Nephrol; 2005 Feb; 16(2):546-54. PubMed ID: 15625070
[TBL] [Abstract][Full Text] [Related]
11. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
12. Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations.
Posthuma N; ter Weel PM; Donker AJ; Peers EM; Oe PL; Verbrugh HA
Nephrol Dial Transplant; 1998 Sep; 13(9):2341-4. PubMed ID: 9761519
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal ultrafiltration and serum icodextrin concentration during dialysis with 7.5% icodextrin solution in Japanese patients.
Ota K; Akiba T; Nakao T; Nakayama M; Maeba T; Park MS; Tranaeus A; Yorioka N;
Perit Dial Int; 2003; 23(4):356-61. PubMed ID: 12968843
[TBL] [Abstract][Full Text] [Related]
14. Correlation between peritoneal permeability and ultrafiltration volume with icodextrin-based peritoneal dialysis solution.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2004; 20():166-9. PubMed ID: 15384820
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal transport characteristics with glucose polymer based dialysate.
Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
[TBL] [Abstract][Full Text] [Related]
16. [Use of icodextrin for diurnal exchange in patients undergoing automatic peritoneal dialysis. Comparison with glucose solutions].
Bajo MA; Selgas R; del Peso G; Castro MJ; Hevia C; Gil F; Costero O; Olea T; Jiménez C
Nefrologia; 2002; 22(4):348-55. PubMed ID: 12369126
[TBL] [Abstract][Full Text] [Related]
17. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.
Jenkins SB; Wilkie ME
Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201
[TBL] [Abstract][Full Text] [Related]
18. Adequacy targets can be met in anuric patients by automated peritoneal dialysis: baseline data from EAPOS.
Brown EA; Davies SJ; Heimbürger O; Meeus F; Mellotte G; Rosman J; Rutherford P; Van Bree M;
Perit Dial Int; 2001; 21 Suppl 3():S133-7. PubMed ID: 11887807
[TBL] [Abstract][Full Text] [Related]
19. Factors related to ultrafiltration volume with icodextrin dialysate use in children.
Mikami N; Hamada R; Harada R; Hamasaki Y; Ishikura K; Honda M; Hataya H
Pediatr Nephrol; 2023 Apr; 38(4):1267-1273. PubMed ID: 36053354
[TBL] [Abstract][Full Text] [Related]
20. Nutritional effects of increasing dialysis dose by adding an icodextrin daytime dwell to Nocturnal Intermittent Peritoneal Dialysis (NIPD) in children.
van Hoeck KJ; Rusthoven E; Vermeylen L; Vandesompel A; Marescau B; Lilien M; Schroder CH
Nephrol Dial Transplant; 2003 Jul; 18(7):1383-7. PubMed ID: 12808177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
